Increased Macrophage Proliferation [PE] - N0000183884
Pharmacologic Class Information
Pharmacologic Code | N0000183884 |
Pharmacologic Name | Increased Macrophage Proliferation |
Pharmacologic Uses |
|
Pharmacologic Concept | Physiologic Effects - [PE] |
Pharmacologic Concept Description | This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept. |
NDC Products with Increased Macrophage Proliferation
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Increased Macrophage Proliferation [PE].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0052-0602 | Tice Bcg | Non-Proprietary Name: Bacillus Calmette-guerin | Powder, For Suspension | Intravesical | Merck Sharp & Dohme Llc | ACTIVE | |
0052-0603 | Bcg Vaccine | Non-Proprietary Name: Bacillus Calmette-guerin Substrain Tice Live Antigen | Injection, Powder, Lyophilized, For Solution | Percutaneous | Merck Sharp & Dohme Llc | ACTIVE |